Technical analysis of BeyondSpring Inc. (BYSI): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer treatments. Its flagship product is Plinabulin, a selective immune-modulating and microtubule-binding agent. Plinabulin has successfully advanced through Phase III clinical trials for two distinct applications: the prevention of chemotherapy-induced neutropenia, and the treatment of advanced non-small cell lung cancer.
Price
| Price | $0.71 |
| Market Cap | $29M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -0.82 |
| EV / EBITDA | -2.91 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -0.00 |
| Current Ratio | 0.70 |
Explore sector: Healthcare · Biotechnology
More sections of BYSI: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks